Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

Nutex Health (NUTX) Cost of Revenue (2017 - 2026)

Nutex Health (NUTX) has disclosed Cost of Revenue for 17 consecutive years, with $4.0 million as the latest value for Q1 2026.

  • For Q1 2026, Cost of Revenue rose 5.47% year-over-year to $4.0 million; the TTM value through Mar 2026 reached $17.4 million, up 26.77%, while the annual FY2025 figure was $17.2 million, 12.8% up from the prior year.
  • Cost of Revenue hit $4.0 million in Q1 2026 for Nutex Health, down from $5.3 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $5.3 million in Q1 2024 and bottomed at $2.4 million in Q4 2024.
  • Average Cost of Revenue over 5 years is $3.7 million, with a median of $3.6 million recorded in 2024.
  • On a YoY basis, Cost of Revenue climbed as much as 168.32% in 2022 and fell as far as 49.7% in 2022.
  • Nutex Health's Cost of Revenue stood at $2.8 million in 2022, then increased by 21.89% to $3.4 million in 2023, then decreased by 29.73% to $2.4 million in 2024, then skyrocketed by 122.54% to $5.3 million in 2025, then decreased by 24.66% to $4.0 million in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $4.0 million, $5.3 million, and $3.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.